A heavily anticipated initial public offering (IPO) from Tilray (NASDAQ:TLRY) finally made its debut on the Nasdaq with a higher price tag than expected on Thursday (July 19).

During its first day in the public market, Tilray’s stock delivered on the anticipation from the investor audience with an offering size of approximately US$153 million. The offering is expected to complete on July 23.


The cannabis producer started offering 9 million shares with an initial price tag of US$23.05 each–an increase from the original plan to sell between US$14 and US$16.

 

Cannabis - Will The Fortune 500 Join The Party?

 
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
 

At the end of Thursday’s trading session TLRY was worth US$22.39 per share.

Tilray will trade its class 2 common stock shares with subordinate voting power under the ticker symbol “TLRY.” The producer’s parent company Privateer Holdings, a private equity firm based in Seattle, holds all of the multiple-voting shares, according to The Globe and Mail.

The shares owned by Privateer will be entitled to 10 votes per share for Tilray’s decisions involving shareholders.

The cannabis producer gave its underwriters in the US and Canada the option to purchase 978,600 and 371,400 additional shares over a 30-day allotment option.

Tilray gives investors another option for a massive cannabis producer with an established medical presence and distribution deals with provinces for recreational sales.

Tilray distribution agreements with B.C. and Manitoba for legal recreational cannabis products set to be sold by the government once the market opens on October 17. The deals were awarded to its subsidiary High Park Company.

Beacon Securities analyst David Kideckel told CNBC he doesn’t see a rush of other Canadian companies looking to launch offerings in a US exchange. However he does see dual listing possibilities.

Cronos Group (TSX:CRON; NASDAQ:CRON) and Canopy Growth (TSX:WEED; NYSE:CGC) already trade on the Nasdaq and New York Stock Exchange (NYSE) respectively.

In Canada the TMX Group, which oversees the Toronto Stock Exchange (TSX) and TSX Venture Exchange (TSXV), prohibited the exposure into the US cannabis sector from any listing. The alternative for companies with assets in the country is to raise capital in the Canadian Securities Exchange (CSE).

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

 

Cannabis - Will The Fortune 500 Join The Party?

 
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
 

Trulieve Cannabis Corp. (“Trulieve” or the “Company”) (CSE: TRUL) (OTCQX: TCNNF), a leading and top-performing cannabis company in the United States today announced the appointment of Marcum LLP (“Marcum”) as its independent registered public accounting firm, effective July 5, 2021 . Marcum was appointed following the resignation of MNP LLP (“MNP”) as the Company’s independent registered public accounting firm effective July 5, 2021 .

“We would like to thank MNP for their guidance and expertise over the past two years and we look forward to working with Marcum as the Company’s new independent registered public accounting firm,” stated Chief Financial Officer, Alex D’Amico.

Keep reading... Show less

Cannabis-infused beverages are not a new product concept, but this summer Canadian drink makers hope consumers will discover them for the first time.

Recreational cannabis beverages have beguiled Canadian producers through different avenues, and many continue to make investments. The promise of these drinks lies in the potential of a more welcoming option for new consumers who may be out of their depth with rolled-up dried flower.

Keep reading... Show less

In the news release, BioHarvest Sciences Inc.‘s First Cannabis Cell Reservoir Produces Ongoing Flowering Stage Cannabinoid Cells For 2 Years, issued 07-Jul-2021 by BioHarvest Sciences Inc. over PR Newswire, we are advised by the company that an incorrect version of the release was issued inadvertently. The complete, corrected release follows:

BioHarvest Sciences Inc.‘s First Cannabis Cell Reservoir Produces Ongoing Flowering Stage Cannabinoid Cells For 2 Years

Keep reading... Show less

Trulieve is the first medical cannabis operator to start planting in the state

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today that it commenced operations in West Virginia . The Company has begun cultivation at their 100,000 square foot size facility in Huntington, West Virginia .

Keep reading... Show less

– The Company demonstrates the efficiency and reliability of its BioFarming technology by reducing production cycle time for Cannabis from 14-23 weeks to 3-4 weeks.

– The Company’s BioFarming technology will allow the Company to harvest 13-17 cycles per year versus 2-4 cycles per year for conventional Cannabis agriculture.

Keep reading... Show less